Status:
UNKNOWN
Pulmonary Disease Among Patients With Systemic Lupus Erythematosus
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
Karolinska University Hospital
Esbjerg Hospital - University Hospital of Southern Denmark
Conditions:
Lupus Erythematosus, Systemic
Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary diseases are common among patients with Systemic Lupus Erythematosus (SLE) and associated with a significantly increased morbidity, mortality, and lower self-reported health related quality ...
Detailed Description
Background Pulmonary diseases are common among patients with Systemic Lupus Erythematosus (SLE) and cover a variety of manifestations including pleuritis and interstitial lung disease. Pulmonary disea...
Eligibility Criteria
Inclusion
- Followed at a Department of Rheumatology in Region Southern Denmark.
- Living in Region Southern Denmark.
- Diagnosed with Systemic Lupus Erythematosus.
- Fulfil the 2019 European League Against Rheumatism / American College of Rheumatology classification criteria.
- Speak and understand spoken and written Danish
Exclusion
- Participants not having their native lungs
- Not participating in visit day, without a valid reason.
Key Trial Info
Start Date :
August 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06087523
Start Date
August 15 2023
End Date
January 1 2026
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense, Region Southern Denmark, Denmark, DK 5000